International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Ibuprofen 5% Gel

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2011 - Volume 15, Number 1
View All Articles in Issue

Page(s): 66

Download in electronic PDF format for $75

Abstract: A formulation for preparing Ibuprofen 5% Gel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, ibuprofen, nonsteroidal anti-inflammatory drug, NSAID, inflammation, pain relief, analgesia, analgesics, topical administration

Related Categories: FORMULATIONS, PAIN MANAGEMENT, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Ibuprofen 5% Gel Allen Loyd V Jr	Jan/Feb 2011 Pg. 66
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K	Mar/Apr 2004 Pg. 101-105
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel Allen Loyd V Jr	May/Jun 2011 Pg. 245
Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules Allen Loyd V Jr	May/Jun 2020 Pg. 227
Ibuprofen 5% Topical Cream Allen Loyd V Jr	May/Jun 2011 Pg. 244
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) Allen Loyd V Jr	Jul/Aug 2020 Pg. 320
Ibuprofen 10-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 67
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Chauhan Nikita N, Patel Jayvadan K	Jan/Feb 2023 Pg. 60-71
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Mar/Apr 2024 Pg. 100-109
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Goodwin Donald A, Fuhram L Clifton	Nov/Dec 1999 Pg. 496-500
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Case Reports: Compounding to Relieve Arthritis Pain Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane	Nov/Dec 2008 Pg. 498-504
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Ketorolac Tromethamine 2% Topical Gel Allen Loyd V Jr	Nov/Dec 2008 Pg. 544
Piroxicam 1% Soft-Patch Topical Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 72
Diclofenac Sodium 1% Soft-Patch Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 65
Diclofenac Sodium 1% Soft-patch Gel Allen Loyd V Jr	Mar/Apr 2024 Pg. 134
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso	Mar/Apr 2021 Pg. 146-155
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 66
Return to Top